PAQ Therapeutics scores $30m Series A
PAQ Therapeutics, a biotechnology company, has raised $30 million in Series A financing.
PAQ Therapeutics, a biotechnology company, has raised $30 million in Series A financing.
Copyright PEI Media
Not for publication, email or dissemination